feed,title,long_url,short_url
r/covid19:2+,[Antivirals] CytoDyn Reaches Enrollment Target of 293 Patients for 2nd DSMC Interim Analysis of Phase 3 COVID-19 Trial and Expects to Enroll the Remaining 97 Patients in the Next Few Weeks to Complete the Trial This Year,https://redd.it/k1vfbe,
